Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026444

Options or other derivatives

  • Chief Commercial Officer acquired 132,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kirby Daniel Gordon Chief Commercial Officer 2026-03-09 Grant or award · Restricted Stock Units +132,200 132,200 D: show line 1 in the form
Loading xslF345X05/tm268453-2_4seq1.xml…